neuroClues Raises €10 Million for Early Detection of Neurological Disorders

French-Belgian medtech neuroClues has secured €10 million in a Series A funding round, boosting its total funding to over €22 million. Their AI-powered headset captures 800 infrared images per eye per second, detecting Parkinson’s and Alzheimer’s years before symptoms arise. With CE certification obtained in January 2025, the company aims for FDA clearance by 2026.